Why does antigenic variation make vaccines difficult to develop for some protozoan diseases?

Antigenic variation significantly complicates the development of vaccines for certain parasitic protozoans, such as trypanosomes, because it allows the parasite to effectively evade the host's immune system.1

When a host's immune system produces antibodies to recognize and neutralize a specific parasite, the organism can shed its surface glycoprotein coat and replace it with one featuring different amino acid sequences. These new forms, known as antigenic variants, render the previous antibodies ineffective. Because a single species may possess hundreds or even thousands of these variants, the host must constantly generate new sets of antibodies to combat each iteration.1

While the host struggles to keep up with these changes, the parasite continues to replicate, often leading to a cycle of infection that the immune system cannot successfully clear. This ability to continuously alter its surface makeup makes creating a stable, effective vaccine for these diseases a formidable challenge.1